Taken together, these data indicate that Gal-9 has diverse immunomodulatory effects depending on concentration and skewing signals available and is therefore likely to have a disease-specific role that needs to be evaluated in depth for both autoimmunity and cancer. This evidence concerns the gene LGALS9 and Autoimmunity.